PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·
K-STREET TRACKER

FOLLOW THE MONEY INTO THE SWAMP

Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.

Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies

💸 Top Spending Clients

#ClientFilingsTotal $
1PFIZER INC.PFE47$46.8M
2GENERAL MOTORS COMPANYGM61$46.8M
3META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA12$44.9M
4VISA INC.V45$37.7M
5AMAZON.COM SERVICES LLCAMZN36$32.8M
6LOCKHEED MARTIN CORPORATIONLMT73$29.0M
7FEDEX CORPORATIONFDX69$27.8M
8ELI LILLY AND COMPANYLLY56$27.1M
9ALTRIA CLIENT SERVICES LLCMO142$25.2M
10AMGEN INCAMGN19$24.9M
11COMCAST CORPORATIONCMCSV179$24.7M
12MERCK & CO INCMRK14$24.0M
13SOUTHERN COMPANYSO53$23.9M
14GOOGLE CLIENT SERVICES LLCGOOGL79$22.6M
15APPLE INCAAPL9$22.1M
16T-MOBILE USA INC.TMUS121$21.0M
17UNITEDHEALTH GROUP INCUNH19$20.4M
18VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ40$20.1M
19OCCIDENTAL PETROLEUM CORPORATIONOXY30$19.7M
20MICROSOFT CORPORATIONMSFT103$18.8M
21QUALCOMM INCORPORATEDQCOM40$17.2M
22GENERAL DYNAMICS CORPGD11$17.0M
23BOEING COMPANYBA23$16.9M
24THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI13$16.9M
25ORACLE CORPORATIONORCL58$16.7M

🎯 Top Lobbied Tickers

#TickerFilingsTotal $
1META
Meta Platforms Inc.
129$50.2M
2PFE
Pfizer Inc.
87$48.6M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
46$37.7M
5AMZN
Amazon.com Inc.
80$35.3M
6LMT
Lockheed Martin Corporation
88$29.4M
7FDX
FedEx Corporation
82$28.3M
8LLY
Eli Lilly and Company
83$28.1M
9AMGN
Amgen Inc.
95$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
64$26.8M
12GOOGL
Alphabet Inc. Class A
123$26.6M
13MO164$26.2M
14SO
Southern Company
108$26.1M
15UNH
UnitedHealth Group Inc.
67$23.9M
16VZ
Verizon Communications Inc.
116$23.8M
17TMUS159$22.7M
18CHTR137$22.6M
19GD
General Dynamics Corporation
127$22.5M
20T
AT&T Inc.
134$21.6M
21ORCL
Oracle Corporation
132$20.6M
22CMCSA
Comcast Corporation
141$20.4M
23CI
The Cigna Group
64$19.9M
24OXY
Occidental Petroleum Corporation
36$19.9M
25MSFT
Microsoft Corporation
122$19.2M

🆕 Filtered Filings · SANOFI U.S. SERVICES INC.

clear filters
DateTickerClientRegistrantAmountIssue
2026-04-20SNYSANOFI U.S. SERVICES INC.W STRATEGIES, LLC$50KPublic Law 119-21: One Big Beautiful Bill Act. Implementation of Inflation Reduction Act. Issues around drug pricing. Education on vaccines.
2026-04-17SNYSANOFI U.S. SERVICES INC.MARSHALL & POPP, LLC$60KIssues related to tariff and trade policy. Issues related to vaccine excise taxes and the Vaccine Injury Compensation Fund. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Issues related to vaccine development, distribution and injury compensation. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including Division J of H.R.7148 - Consolidated Appropriations Act, 2026, PL 119-75. Issues related to the 340B program. Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patie
2026-01-20SNYSANOFI U.S. SERVICES INC.W STRATEGIES, LLC$50KPublic Law 119-21: One Big Beautiful Bill Act. Implementation of Inflation Reduction Act. Issues around drug pricing.
2026-01-16SNYSANOFI U.S. SERVICES INC.MARSHALL & POPP, LLC$60KIssues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Issues related to vaccine development, distribution and injury compensation. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices. Issues related to the 340B program. Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act. Issues related to tariff and trade policy. Issues related to vaccine excise taxes and the Vaccine Injury Compensation Fund.
2025-10-20SNYSANOFI U.S. SERVICES INC.MARSHALL & POPP, LLC$60KIssues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program Issues related to vaccine development, distribution and injury compensation. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices. Issues related to the 340B program. Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041; Affordable Prescriptions for Patients Act. Issues related to tariff and trade policy. Issues related to vaccine excise taxes and the Vaccine Injury Compensation Fund.
2025-10-20SNYSANOFI U.S. SERVICES INC.W STRATEGIES, LLC$50KPublic Law 119-21: One Big Beautiful Bill Act. Implementation of Inflation Reduction Act.
2025-07-21SNYSANOFI U.S. SERVICES INC.MARSHALL & POPP, LLC$60KIssues related to prescription drug value, including H.R. 1, FY25 budget reconciliation, implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program Issues related to vaccine development, distribution and injury compensation. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including H.R. 1, FY25 budget reconciliation. Issues related to the 340B program. Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041; Affordable Prescriptions for Patients Act. Issues related to tariff and trade policy. Issues related to vaccine excise taxes and the Vaccine Injury Compensation F
2025-07-21SNYSANOFI U.S. SERVICES INC.W STRATEGIES, LLC$50KH.R.1 - One Big Beautiful Bill Act." Implementation of Inflation Reduction Act. H.R.1492 - EPIC Act of 2025.
2025-04-21SNYSANOFI U.S. SERVICES INC.MARSHALL & POPP, LLC$60KIssues related to prescription drug value, including H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; and implementation of the Inflation Reduction Act (PL 117-169). Issues related to vaccine development, distribution and injury compensation. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including H.R. 2882, FY2024 Further Consolidated Appropriations Act. Issues related to the 340B program. Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041; Affordable Prescriptions for Patients Act. Issues related to tariff and trade policy. Issues related to vaccine excise taxes and the Vaccine Injury Compensation Fund. Issues related to budget reconciliation, including H.Con.Res. 14 and S.Con.Res. 7.
2025-04-21SNYSANOFI U.S. SERVICES INC.W STRATEGIES, LLC$50KImplementation of Inflation Reduction Act. H.R.1492 - EPIC Act of 2025.
2025-01-21SNYSANOFI U.S. SERVICES INC.MARSHALL & POPP, LLC$60KIssues related to vaccine excise taxes and the Vaccine Injury Compensation Fund. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to vaccine development, distribution and injury compensation. Issues related to insulin pricing. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including S. 127, Pharmacy Benefit Manager Transparency Act, S.1339 - Pharmacy Benefit Manager Reform Act, H.R. 2679, the PBM Accountability Act, H.R.4822 - Health Care Price Transparency Act, H.R. 5378 - Lower Costs, More Transparency Act. Issues related to the 340B program, including H.R. 3290, to ensure transparency and oversight of the 340B drug discount program. Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act. Issues related to Type 1 diabetes scre
2025-01-21SNYSANOFI U.S. SERVICES INC.W STRATEGIES, LLC$50KImplementation of H.R.5376 - Inflation Reduction Act of 2022. Issues relating to the Medicaid Drug Rebate Program. Legislation around Vaccine Injury Compensation Modernization. Reauthorization of Pandemic All Hazards Preparedness (PAHPA) Act. H.R.2923 - Living Donor Protection Act of 2023. H.R.5378 - Lower Costs, More Transparency Act. H.R.10545 - American Relief Act, 2025 as it relates to PBM reform.